Integrated Substance Use and Mental Health Treatment for Adolescents: Aligning Organizational and Financial Incentives
ABSTRACT The high prevalence of the dual diagnosis of mental and substance use disorders (SUD) has been increasingly documented for both adolescents and adults (Crowley and Riggs 1995; Kandel et al. 1999; Whitmore et al. 1997). For more than a decade, the National Institute of Drug Abuse (NIDA) has included integrated treatment of comorbid psychiatric disorders as one of nine core treatment principles (National Institute on Drug Abuse 1999). Despite empirically supported practice guidelines, implementation of integrated treatment has been slow (New Freedom Commission on Mental Health 2003; U.S. Department of Health and Human Services 1999). In response to the growing call for integrated treatments and systems of care, this paper: (1) identifies systemic and economic barriers that have impeded widespread implementation of integrated care for adolescents with co-occurring SUD, specifically the supply of treatment providers, shifting priorities of gatekeepers to specialty care, and financing streams; and (2) describes possibilities for aligning economic incentives in order to facilitate the dissemination and implementation of integrated care for adolescents with co-occurring SUD.
- SourceAvailable from: Howard A. Liddle
[Show abstract] [Hide abstract]
- "Combined treatments refer to integrated behavioural and pharmacological interventions for cooccurring substance use and mental health disorders (Mattson and Litten, 2005). In the case of adolescent substance users, combined treatment refers to integrating a pharmacological intervention to treat a co-occurring mental health disorder for which effective medications exist, such as attention-deficit hyperactivity disorder, anxiety and depression (Bukstein and Cornelius, 2006; Libby and Riggs, 2005). Although resources exist for treating 'dual-disorder' adult clients (e.g. "
ABSTRACT: This article provides an overview of controlled trials research on treatment processes and outcomes in family-based approaches for adolescent substance abuse. Outcome research on engagement and retention in therapy, clinical impacts in multiple domains of adolescent and family functioning, and durability and moderators of treatment effects is reviewed. Treatment process research on therapeutic alliance, treatment fidelity and core family therapy techniques, and change in family processes is described. Several important research issues are presented for the next generation of family-based treatment studies focusing on delivery of evidence-based treatments in routine practice settings.Journal of Family Therapy 05/2009; 31(2):126-154. DOI:10.1111/j.1467-6427.2009.00459.x · 1.02 Impact Factor
Conference Paper: Silver-Iron Batteries for Manned and Unmanned VehiclesOCEANS '89. Proceedings; 10/1989
- Journal of the American Academy of Child & Adolescent Psychiatry 10/2006; 45(9):1138-41. DOI:10.1097/01.chi.0000228126.34085.79 · 7.26 Impact Factor